EDA and cardiovascular disorder: In contrast to several fetal Tn-C variants, for ED-A+ Fn there are only very limited data concerning its potential impact as serum biomarker in cardiovascular diseases and, to our best knowledge, there is currently no study available in the literature reporting on the role of that molecule as potential biomarker in pulmonary hypertension.